Results 191 to 200 of about 35,299 (221)

Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine programme in Malawi, a modelling study. [PDF]

BMC Med
Phiri J, Sibale L, Mlongoti L, Mitole N, Kusakala A, Khwiya M, Kayembe T, Lisimba E, Kapwata P, Malisita K, Chaguza C, Ferreira DM, Thindwa D, Jambo K.   +13 more
europepmc   +1 more source

The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory. [PDF]

Vaccines (Basel)
Tzovara I, Papadatou I, Tzanoudaki M, Piperi C, Kanaka-Gantenbein C, Spoulou V.   +5 more
europepmc   +1 more source

Knowledge of caregivers regarding pneumococcal diseases and pneumococcal conjugate vaccine (PCV): A cross sectional study at a district in India. [PDF]

Vaccine X
Majumder J, Ray A, Haldar P, Deb Roy A, Roy D, Chandra Mandal N, Mahapatra T.   +6 more
europepmc   +1 more source

Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction and Before a Schedule Change. [PDF]

Open Forum Infect Dis
Childs L, Ouedraogo I, Zoma RL, Tarbangdo TF, Sawadogo G, Aké HF, Ouangraoua S, Sanou S, Tran T, Velusamy S, Adebanjo T, Van Beneden CA, McGee L, Kobayashi M.   +13 more
europepmc   +1 more source

Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine

, 2008
Baker, S., Daniels, E., Dymond, S., Faust, S.N., Finn, A., Galiza, E., Gruber, W., Heath, P.T., John, T., Klinger, C., Layton, H., Pestridge, S., Pollard, A., Scott, D., Snape, M., Tansey, S.   +15 more
core  

Correction to: Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. [PDF]

Clin Infect Dis
europepmc   +1 more source